Učitavanje...
Pelacarsen for lowering lipoprotein(a): implications for patients with chronic kidney disease
Chronic kidney disease (CKD) patients are at an increased risk of cardiovascular disease (CVD) and statins may not be protective in advanced CKD. The reasons for the limited efficacy of statins in advanced CKD are unclear, but statins may increase plasma levels of the highly atherogenic molecule lip...
Spremljeno u:
| Izdano u: | Clin Kidney J |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7577764/ https://ncbi.nlm.nih.gov/pubmed/33123354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfaa001 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|